Introduction Acute bacterial skin and skin structure infections (ABSSSIs) are a subtype of
skin and soft tissue infections (SSTI), usually sustained by Gram-positive bacteria, whose …

Bone and joint infections (BJI) require prolonged antimicrobial treatment, leading to lengthy
hospitalizations, high costs, the risk of nosocomial infections, and the development of …

ABSTRACT Introduction Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) are a
common reason of Emergency Department (ED) access and account for a considerable …

Dalbavancin is a semisynthetic lipoglycopeptide, which possesses great potential for
bactericidal activity similar to antimicrobials with the same mechanism of action, such as …

Purpose Although dalbavancin is currently approved for the treatment of ABSSIs, several
studies suggest its efficacy and tolerance as long-term therapy for other off-label indications …

Dalbavancin is increasingly being used for long-term treatment of subacute and chronic
staphylococcal infections. In this study, a new Bayesian model was implemented and …

Dalbavancin, a long-acting lipoglycopeptide antibiotic targeting susceptible Gram-positive
bacteria, is WHO critically important antibiotic, increasingly used in critical situations such as …

Introduction Infections due to multidrug-resistant organisms (MDRO) are a serious concern
for public health with high morbidity and mortality. Though many antibiotics have been …

Long-acting lipoglycopeptides (LGPs), such as dalbavancin and oritavancin, are
semisynthetic antibiotics known for their strong effectiveness against a wide array of Gram …

The overall low-quality evidence concerning the clinical benefits of different antibiotic
regimens for the treatment of infective endocarditis (IE), which has made it difficult to strongly …